Skip to main content
. Author manuscript; available in PMC: 2011 Apr 2.
Published in final edited form as: J Control Release. 2009 Dec 16;143(1):13–22. doi: 10.1016/j.jconrel.2009.12.010

Table 1.

Liposome compositions

Liposome # Lipid formulation (Short description) Composition (molar ratios) Size (nm) Osmolarity (mOsm) References
I SoyPC:Chol:DSPE-PEG2k (High cholesterol/long circulating) 56:39:5 91 ±24 300 [37]
II DPPC:SoyPC:Chol:DSPE-PEG2k (Temperature sensitive/long circulating) 54:27:16:3 99 ±8 300 [38]
III DPPC:lyso-PalmitoylPC:DSPE-PEG2k (Lysolipid temperature sensitive) 86:10:4 95 ±25 300 [39]
IV DPPC:lyso-PalmitoylPC:Ceramide-PEG2k (Ceramide-PEG version of III) 86:10:4 101 ±22 300 [39, 40]
V DPPC:DSPC:DSPE-PEG2k (Classical temperature sensitive) 85.5:9.5:5 80 ±21 300 [41]
VI DPPC:DSPC:Comb-PEG (Comb-PEG version of V) 89.1:9.9:1 113 ±27 300 [41, 42]
VII, VIII, IX DPPC:DSPC:Ceramide-PEG2k (Ceramide-PEG versions of V with varied osmolarity) 85.5:9.5:5 99 ±14, 94 ±17, 92 ±20 300, 38, 10 [40, 41]
HHS Vulnerability Disclosure